USPTO 2015–2025 USPTO PatentsView US Corporation

Mynosys Cellular Devices, Inc.

USPTO PatentsView assignee record - 10 granted patents across 2 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

10
Total patents granted
2
CPC technology areas
23.7
Avg claims per patent
-100%
5-year filing velocity

The verdict

Mynosys holds 10 US patents across 2 technology areas, rank #26,912 of 50,000 tracked assignees.

#26,912
of 50,000 US assignees by volume
Top 76%
by Innovation Score (27.5/100)
23.7
avg claims per patent
-100%
filing velocity, last 5 yrs

Portfolio overview

Mynosys Cellular Devices, Inc. has been granted 10 US utility patents between 2015 and 2019, placing Mynosys Cellular Devices, Inc. at rank #26,912 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.7 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Mynosys Cellular Devices, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Mynosys sits between Multisensor Scientific, Inc. (10 patents, rank #26,908) and Nanjing Institute OF Environmental Sciences, Ministry OF Ecology AND Environment (10 patents, rank #26,916) - the closest US assignees by grant volume. The composite Innovation Score of 27.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 10 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Mynosys Cellular Devices, Inc.'s 23.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Mynosys Cellular Devices, Inc. against peers pursuing similar technology classes.

Who files at Mynosys's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Mynosys holds 10 patents at rank #26,912, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Mynosys

By rank, the assignees closest to #26,912 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Mynosys's primary technology class.

Mynosys's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

28 Top 76% higher than 24% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). This entry sits in this band. 30–40: 15,294 US assignees (31%). Above this entry. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2015201620182019 4
USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Mynosys Cellular Devices, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 10.0%
2016 3 30.0%
2018 2 20.0%
2019 4 40.0%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#26,912

Across all tracked assignees

Innovation Score

27.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Mynosys Cellular Devices, Inc. hold?
Mynosys Cellular Devices, Inc. holds 10 US granted patents filed between 2015 and 2019, spanning 2 technology areas.
What is Mynosys Cellular Devices, Inc.'s Innovation Score?
Mynosys Cellular Devices, Inc. has an Innovation Score of 27.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Mynosys Cellular Devices, Inc. focus on?
Mynosys Cellular Devices, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 10 patents. The company has filed patents in 2 CPC subclasses total.
Is Mynosys Cellular Devices, Inc.'s patent filing rate increasing or decreasing?
Mynosys Cellular Devices, Inc.'s recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Mynosys Cellular Devices, Inc.'s patents?
Mynosys Cellular Devices, Inc.'s patents average 23.7 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Mynosys Cellular Devices, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Mynosys's 10 grants land it in the top 76% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Mynosys ranks #26,912 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.